BlueRiver Acquisition Corp.
BLUA
New York Stock Exchange11.00
USD
+0.01
- -
CIK
0001831006
ISIN
KYG1261Q1073
CUSIP
G1261Q107
Return %
Stock
S&P500
1Y
4.36
26.84
3Y
13.99
77.03
5Y
13.29
80.55
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- John F. Gregg
- Full Time Employees
- 3
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 250 West Nottingham Drive San Antonio TX United States of America 78209
- IPO Date
- Mar 22, 2021
- CIK
- 0001831006
- Website
- blueriverspac.com
- Similar Companies
- Business
- BlueRiver Acquisition Corp. BlueRiver Acquisition Corp. (NYSE American: BLUA) is a blank-check special purpose acquisition company formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company offers no operating products or services of its own but provides a public-market conduit for target companies via its SPAC structure; it maintains a trust account holding proceeds from its 2021 initial public offering of 28.75 million units at $10 each, inclusive of over-allotment, alongside private placement units from sponsor BlueRiver Ventures LLC; redeemable Class A ordinary shares, non-redeemable Class A shares, Class B founder shares, and warrants exercisable at $11.50 comprise its primary equity and derivative instruments. Incorporated in 2020 as a Cayman Islands exempted company and headquartered at 250 West Nottingham Drive, Suite 400 in San Antonio, Texas, BlueRiver Acquisition Corp. targets opportunities primarily in technology, media, telecom, and entertainment sectors across North America, Europe, and Asia, leveraging management expertise from Co-CEOs John Gregg and Randall Mays. In July 2023, the company entered a definitive merger agreement with Spinal Stabilization Technologies LLC, a medical device developer, envisioning a domestication to Delaware, subsidiary merger, and post-combination listing under the SST name with an enterprise value of about $302 million assuming full redemptions and a proposed $40 million PIPE; the deal remains pending without completion as of mid-2025 amid high redemptions totaling over 27 million public shares across multiple extensions. Shareholders approved extensions in January and August 2023 to push the combination deadline from February to August 2023 and then to February 2024; further votes in February 2024 authorized up to six additional one-month extensions via monthly trust deposits of $0.025 per unredeemed share, with deposits made through April 2024 extending to June; a June 2025 proxy seeks approval for up to four more three-month extensions to August 2026, noting no letter of intent or definitive agreement currently exists. The company transferred its listing from NYSE to NYSE American in March 2023 and faced delisting proceedings in February 2024 for failing to complete a deal within 36 months, triggering a review hearing; it holds one inactive subsidiary, BLUA Merger Sub LLC, formed in Texas in July 2023.
NYSE American to Suspend Trading in BlueRiver Acquisition Corp. (BLUA)
BlueRiver Acquisition Corp. Receives Commencement of Delisting Notice From NYSE American; Announces Extension of Merger Agreement
NYSE American to Commence Delisting Proceedings Against BlueRiver Acquisition Corp. (BLUA)